Anal Cancer

• CLINICAL_TRIALS trial_result · 2012-07-20
  Clinical Trial Update: Assessment of Symptom-Related Cytokines in Lung and Gastrointestinal (GI) Cancer Patients

  A completed clinical trial evaluating symptom-related cytokines in patients with anal cancer, colorectal cancer, esophageal cancer, gastric …

• CLINICAL_TRIALS trial_result · 2012-07-16
  Clinical Trial Update: Phase I Vandetanib Plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal Cancer [Phase 1]

  A Phase I trial tested vandetanib in combination with capecitabine, oxaliplatin and bevacizumab for metastatic colorectal cancer; the study …

• CLINICAL_TRIALS trial_result · 2011-09-08
  Clinical Trial Update: Immunogenicity and Reactogenicity of Alternative Schedules of Gardasil [NA]

  This clinical trial update reports immunogenicity and reactogenicity data for alternative dosing schedules of Gardasil, the HPV vaccine; res…

• CLINICAL_TRIALS trial_result · 2011-08-04
  Clinical Trial Update: Cancer in Patients With Gabapentin (GPRD)

  This clinical trial update reports cancer outcomes in patients treated with gabapentin, with results posted in 2011. It lists several cancer…

• CLINICAL_TRIALS trial_result · 2011-06-22
  Clinical Trial Update: Cidofovir in Treating HIV-Infected Patients With High-Grade Squamous Intraepithelial Lesions of the Skin Near the Anus [Phase 2]

  Phase 2 trial evaluating cidofovir in HIV-infected patients with high-grade squamous intraepithelial lesions near the anus; the study is com…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2011-06-22
  Clinical Trial Update: Hybrid Capture 2 Human Papiloma Virus (HPV) High-Risk Anal DNA Test [NA]

  This clinical trial update reports completion of a study evaluating the Hybrid Capture 2 High-Risk HPV DNA test for diagnosing anal canal HP…

• CLINICAL_TRIALS trial_result · 2010-06-25
  Clinical Trial Update: Molecular Biology of Anal Cancer in HIV-Positive Patients

  The clinical trial updating the molecular biology of anal cancer in HIV-positive patients has completed.